Positive early Alzheimer’s trial results for repurposed cancer drug

Encouraging results from a small Phase 2 human trial testing the effects of a cancer drug in treating Alzheimer’s disease have been published in the journal Annals of Neurology. The data suggests the drug is safe, well-tolerated and alters biomarkers associated with Alzheimer’s. A larger efficacy study is currently planned.
Tags: Alzheimer’s Disease, Dementia, Brain, Protein, Parkinson’s Disease, Georgetown University
Continue reading Positive early Alzheimer’s trial results for repurposed cancer drug
